Advertisement

Topics

NeuroVision Announces Participation in Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology

20:19 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Substudy Will Evaluate NeuroVision’s Novel Retinal Imaging Technology NeuroVision Imaging LLC (“NeuroVision”) today announced its participation in a new substudy with investigators at the University of Californi...

Other Sources for this Article

for NeuroVision Imaging LLC
Sandy Van, 808-526-1708
Cell/Text: 808-206-4576
sandy@prpacific.com

NEXT ARTICLE

More From BioPortfolio on "NeuroVision Announces Participation in Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...